Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-023745
Filing Date
2024-09-20
Accepted
2024-09-20 16:09:47
Documents
1
Period of Report
2024-09-18

Document Format Files

Seq Description Document Type Size
1 form4-09202024_080944.html 4  
1 form4-09202024_080944.xml 4 7501
  Complete submission text file 0001415889-24-023745.txt   9039
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SUTRO BIOPHARMA, INC. 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Gerber Hans-Peter (Reporting) CIK: 0001992979 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 241313480